Search research articles
Contact Us
Filters
Showing results (471-480 of 488) with videos related to
Page
of 49
Sort By:
Psychoneuroendocrinology
|
April 27, 2023
Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection
A Nuber-Champier, A Cionca, G Breville, et al.
Brain Communications
|
July 7, 2023
Markers of limbic system damage following SARS-CoV-2 infection
Marine Thomasson, Philippe Voruz, Alexandre Cionca, et al.
Human Brain Mapping
|
December 2, 2022
Brain functional connectivity alterations associated with neuropsychological performance 6-9 months following SARS-CoV-2 infection
Philippe Voruz, Alexandre Cionca, Isabele Jacot de Alcântara, et al.
Orphanet Journal of Rare Diseases
|
October 28, 2025
French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease
Fabrice Camou, Christine Serratrice, Magali Pettazzoni, et al.
BMJ Open
|
November 29, 2024
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)
Jerome Stirnemann, Jacques Serratrice, Tamara Mann, et al.
QJM : Monthly Journal of the Association of Physicians
|
March 22, 2013
Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases
C Bernard, D Maucort-Boulch, L Varron, et al.
Orphanet Journal of Rare Diseases
|
October 11, 2012
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients
Jérôme Stirnemann, Marie Vigan, Dalil Hamroun, et al.
Journal of Clinical Medicine
|
July 26, 2020
A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease
Christine Serratrice, Jérôme Stirnemann, Amina Berrahal, et al.
International Journal of Molecular Sciences
|
February 20, 2020
Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry
Yann Nguyen, Jérôme Stirnemann, Florent Lautredoux, et al.
Journal of Internal Medicine
|
February 28, 2026
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation
Maxime Beydon, Jérôme Stirnemann, Karima Yousfi, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 488) with videos related to
Sort By:
Page
of 49
Psychoneuroendocrinology
|
April 27, 2023
Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection
A Nuber-Champier, A Cionca, G Breville, et al.
Brain Communications
|
July 7, 2023
Markers of limbic system damage following SARS-CoV-2 infection
Marine Thomasson, Philippe Voruz, Alexandre Cionca, et al.
Human Brain Mapping
|
December 2, 2022
Brain functional connectivity alterations associated with neuropsychological performance 6-9 months following SARS-CoV-2 infection
Philippe Voruz, Alexandre Cionca, Isabele Jacot de Alcântara, et al.
Orphanet Journal of Rare Diseases
|
October 28, 2025
French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease
Fabrice Camou, Christine Serratrice, Magali Pettazzoni, et al.
BMJ Open
|
November 29, 2024
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)
Jerome Stirnemann, Jacques Serratrice, Tamara Mann, et al.
QJM : Monthly Journal of the Association of Physicians
|
March 22, 2013
Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases
C Bernard, D Maucort-Boulch, L Varron, et al.
Orphanet Journal of Rare Diseases
|
October 11, 2012
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients
Jérôme Stirnemann, Marie Vigan, Dalil Hamroun, et al.
Journal of Clinical Medicine
|
July 26, 2020
A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease
Christine Serratrice, Jérôme Stirnemann, Amina Berrahal, et al.
International Journal of Molecular Sciences
|
February 20, 2020
Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry
Yann Nguyen, Jérôme Stirnemann, Florent Lautredoux, et al.
Journal of Internal Medicine
|
February 28, 2026
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation
Maxime Beydon, Jérôme Stirnemann, Karima Yousfi, et al.
Page
of 49